Evaluation of Retinal Microvascular Change That May Develop in After Open Globe Injury

November 27, 2024 updated by: Aslı Çetinkaya Yaprak, Akdeniz University

Evaluation of Retinal Microvascular Change That May Develop in After Open Globe Injury With Optical Coherence Tomography

The aim of this study is to evaluate posterior segment changes in the non-traumatic eye after open globe injury.

Study Overview

Status

Completed

Conditions

Detailed Description

Globe injuries can be classified as either closed- or open-globe injuries, based on the integrity of the sclera and cornea. Open-globe injury (OGI) is characterized by a full-thickness wound of the ocular wall.

As one of the most severe forms of ocular trauma, open-globe injury (OGI) causes significant vision loss. Timely and meticulous repair of these injuries can improve patient outcomes.

OGI by rupture often occurs at the weakest point of the eye wall, which may or may not be at the actual injury site. The rupture site is most commonly found in the sclera concentric to the limbus, just posterior to the insertion of the extraocular muscles.

After trauma, changes may occur in the non-trauma eye. Retinal and choroidal circulation may change as a result of adaptation mechanisms. In this study, we evaluated the vascular densities of the control group and post-traumatic non-trauma eye.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antalya, Turkey, 070059
        • Aslı Çentinkaya Yaprak
      • Antalya, Turkey, 07070
        • Yusuf Samet Atlıhan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Middle age, predominantly male

Description

Inclusion Criteria:

  • Be over 18 years old
  • Unilateral eye injury

Exclusion Criteria:

  • Be under the age of 18
  • Usage of systemic drugs or topical ocular drops
  • Bilateral eye injury
  • Having systemic disease, having ocular pathology that may decrease visual acuity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Trauma Group
Non-trauma eye after open globe injury determine retinal microvascular changes
Measurements of best-corrected visual acuity, refractive error, intraocular pressure, axial length, slit lamp examination of the anterior segment, dilated fundus examination, and anterior segment parameters, optical coherence tomography angiography (OCTA)
Other Names:
  • Biometry
  • Auto refractometry
  • Non contact tonometry
  • Optical Coherence Tomography Angiography (OCTA)
Control Group
Investigation of retinal microvascular circulation in age- and sex-matched healthy volunteers
Measurements of best-corrected visual acuity, refractive error, intraocular pressure, axial length, slit lamp examination of the anterior segment, dilated fundus examination, and anterior segment parameters, optical coherence tomography angiography (OCTA)
Other Names:
  • Biometry
  • Auto refractometry
  • Non contact tonometry
  • Optical Coherence Tomography Angiography (OCTA)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Corneal Thickness
Time Frame: 10 minutes
Corneal thickness in mikrometer value
10 minutes
Anterior Chamber Volume
Time Frame: 10 minutes
Anterior chamber volume in mm3
10 minutes
Anterior Chamber Depth
Time Frame: 10 minutes
Anterior chamber depth in mm
10 minutes
Anterior Chamber Angle
Time Frame: 10 minutes
Anterior chamber angle in degree
10 minutes
Lens Power
Time Frame: 10 minutes
in diopters
10 minutes
Steep Keratometry
Time Frame: 10 minutes
in Diopters measured with pentacam
10 minutes
Tonometry
Time Frame: 10 minutes
Intraocular pressure measurement in mmHg
10 minutes
Axial Length
Time Frame: 10 minutes
Axial length in mm
10 minutes
Optic Nerve Head Vessel Density
Time Frame: 10 minutes
Optic nerve head vessel density assessed with optical coherence tomography angiography
10 minutes
Choriocapillaris Flow Area
Time Frame: 10 minutes
Choriocapillaris flow area assessed with optical coherence tomography angiography
10 minutes
Subfoveal Central Macular Thickness
Time Frame: 10 minutes
Subfoveal central macular thickness assessed with optical coherence tomography
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yusuf Samet Atlıhan, MD, 1, Akdeniz University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2024

Primary Completion (Actual)

September 2, 2024

Study Completion (Actual)

September 2, 2024

Study Registration Dates

First Submitted

March 6, 2023

First Submitted That Met QC Criteria

March 6, 2023

First Posted (Actual)

March 16, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

November 27, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eye Injury Trauma

Clinical Trials on Comprehensive Ophthalmologic Examination

Subscribe